▶ 調査レポート

化学療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
• 英文タイトル：Global Chemotherapy Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。化学療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） / Global Chemotherapy Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR08C1196資料のイメージです。• レポートコード：B-GIR08C1196
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、120ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare
• 販売価格（消費税別）
  Single User￥515,040 (USD3,480)▷ お問い合わせ
  Corporate User￥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートは、化学療法薬の世界市場について調べ、まとめました。種類別セグメントは、代謝拮抗物質、植物アルカロイド、アルキル化剤、抗腫瘍抗生物質等、用途別セグメントは、等に区分しました。化学療法薬の世界市場概観、企業動向、企業別化学療法薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・化学療法薬の市場概観
・化学療法薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・化学療法薬の企業別販売動向、市場シェア、市場集中度、競争動向
・化学療法薬の世界市場規模
・化学療法薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・化学療法薬のアメリカ市場規模推移
・化学療法薬のカナダ市場規模推移
・化学療法薬のメキシコ市場規模推移
・化学療法薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・化学療法薬のドイツ市場規模推移
・化学療法薬のイギリス市場規模推移
・化学療法薬のロシア市場規模推移
・化学療法薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・化学療法薬の日本市場規模推移
・化学療法薬の中国市場規模推移
・化学療法薬の韓国市場規模推移
・化学療法薬のインド市場規模推移
・化学療法薬の東南アジア市場規模推移
・化学療法薬の南米市場分析（ブラジル、アルゼンチン等）
・化学療法薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・化学療法薬の種類別分析/販売量、売上、市場シェア（代謝拮抗物質、植物アルカロイド、アルキル化剤、抗腫瘍抗生物質）
・化学療法薬の用途別分析/市場規模（）
・化学療法薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・化学療法薬の販売チャネル・代理店・貿易業者・ディーラー分析

Chemotherapy is the use of any drug to treat any disease. But to most people, the wordchemotherapy means drugs used for cancer treatment.

Scope of the Report:
The global Chemotherapy Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chemotherapy Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Chemotherapy Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chemotherapy Drug market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Eli Lilly
CELGENE
Bristol-Myers Squibb
Merck
GlaxoSmithKline
Novartis
Sanofi
Teva Pharmaceuticals Industries

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antimetabolites
Plant Alkaloids
Alkylating Agents
Antitumor Antibiotics

Market Segment by Applications, can be divided into
Oral
Intravenous

レポート目次

Table of Contents

1 Chemotherapy Drug Market Overview
1.1 Product Overview and Scope of Chemotherapy Drug
1.2 Classification of Chemotherapy Drug by Types
1.2.1 Global Chemotherapy Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Chemotherapy Drug Revenue Market Share by Types in 2018
1.2.3 Antimetabolites
1.2.4 Plant Alkaloids
1.2.5 Alkylating Agents
1.2.6 Antitumor Antibiotics
1.3 Global Chemotherapy Drug Market by Application
1.3.1 Global Chemotherapy Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Oral
1.3.3 Intravenous
1.4 Global Chemotherapy Drug Market by Regions
1.4.1 Global Chemotherapy Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Chemotherapy Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chemotherapy Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemotherapy Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Chemotherapy Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemotherapy Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Chemotherapy Drug (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Chemotherapy Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Chemotherapy Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 CELGENE
2.3.1 Business Overview
2.3.2 Chemotherapy Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CELGENE Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Chemotherapy Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Chemotherapy Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Chemotherapy Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Chemotherapy Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Chemotherapy Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teva Pharmaceuticals Industries
2.9.1 Business Overview
2.9.2 Chemotherapy Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceuticals Industries Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Chemotherapy Drug Market Competition, by Players
3.1 Global Chemotherapy Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemotherapy Drug Players Market Share
3.2.2 Top 10 Chemotherapy Drug Players Market Share
3.3 Market Competition Trend
4 Global Chemotherapy Drug Market Size by Regions
4.1 Global Chemotherapy Drug Revenue and Market Share by Regions
4.2 North America Chemotherapy Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Chemotherapy Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Chemotherapy Drug Revenue and Growth Rate (2014-2019)
4.5 South America Chemotherapy Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Chemotherapy Drug Revenue and Growth Rate (2014-2019)
5 North America Chemotherapy Drug Revenue by Countries
5.1 North America Chemotherapy Drug Revenue by Countries (2014-2019)
5.2 USA Chemotherapy Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Chemotherapy Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Chemotherapy Drug Revenue and Growth Rate (2014-2019)
6 Europe Chemotherapy Drug Revenue by Countries
6.1 Europe Chemotherapy Drug Revenue by Countries (2014-2019)
6.2 Germany Chemotherapy Drug Revenue and Growth Rate (2014-2019)
6.3 UK Chemotherapy Drug Revenue and Growth Rate (2014-2019)
6.4 France Chemotherapy Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Chemotherapy Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Chemotherapy Drug Revenue by Countries
7.1 Asia-Pacific Chemotherapy Drug Revenue by Countries (2014-2019)
7.2 China Chemotherapy Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Chemotherapy Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Chemotherapy Drug Revenue and Growth Rate (2014-2019)
7.5 India Chemotherapy Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
8 South America Chemotherapy Drug Revenue by Countries
8.1 South America Chemotherapy Drug Revenue by Countries (2014-2019)
8.2 Brazil Chemotherapy Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Chemotherapy Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Chemotherapy Drug by Countries
9.1 Middle East and Africa Chemotherapy Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Chemotherapy Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Chemotherapy Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Chemotherapy Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Chemotherapy Drug Revenue and Growth Rate (2014-2019)
10 Global Chemotherapy Drug Market Segment by Type
10.1 Global Chemotherapy Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Chemotherapy Drug Market Forecast by Type (2019-2024)
10.3 Antimetabolites Revenue Growth Rate (2014-2024)
10.4 Plant Alkaloids Revenue Growth Rate (2014-2024)
10.5 Alkylating Agents Revenue Growth Rate (2014-2024)
10.6 Antitumor Antibiotics Revenue Growth Rate (2014-2024)
11 Global Chemotherapy Drug Market Segment by Application
11.1 Global Chemotherapy Drug Revenue Market Share by Application (2014-2019)
11.2 Chemotherapy Drug Market Forecast by Application (2019-2024)
11.3 Oral Revenue Growth (2014-2019)
11.4 Intravenous Revenue Growth (2014-2019)
12 Global Chemotherapy Drug Market Size Forecast (2019-2024)
12.1 Global Chemotherapy Drug Market Size Forecast (2019-2024)
12.2 Global Chemotherapy Drug Market Forecast by Regions (2019-2024)
12.3 North America Chemotherapy Drug Revenue Market Forecast (2019-2024)
12.4 Europe Chemotherapy Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Chemotherapy Drug Revenue Market Forecast (2019-2024)
12.6 South America Chemotherapy Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Chemotherapy Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Chemotherapy Drug Picture
Table Product Specifications of Chemotherapy Drug
Table Global Chemotherapy Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Chemotherapy Drug Revenue Market Share by Types in 2018
Figure Antimetabolites Picture
Figure Plant Alkaloids Picture
Figure Alkylating Agents Picture
Figure Antitumor Antibiotics Picture
Table Global Chemotherapy Drug Revenue (Million USD) by Application (2014-2024)
Figure Chemotherapy Drug Revenue Market Share by Applications in 2018
Figure Oral Picture
Figure Intravenous Picture
Table Global Market Chemotherapy Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Chemotherapy Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Chemotherapy Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Chemotherapy Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Chemotherapy Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Chemotherapy Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Chemotherapy Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Chemotherapy Drug Type and Applications
Table Pfizer Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Chemotherapy Drug Type and Applications
Table Eli Lilly Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table CELGENE Basic Information, Manufacturing Base and Competitors
Table CELGENE Chemotherapy Drug Type and Applications
Table CELGENE Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Chemotherapy Drug Type and Applications
Table Bristol-Myers Squibb Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Chemotherapy Drug Type and Applications
Table Merck Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Chemotherapy Drug Type and Applications
Table GlaxoSmithKline Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chemotherapy Drug Type and Applications
Table Novartis Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Chemotherapy Drug Type and Applications
Table Sanofi Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Industries Chemotherapy Drug Type and Applications
Table Teva Pharmaceuticals Industries Chemotherapy Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Chemotherapy Drug Revenue (Million USD) by Players (2014-2019)
Table Global Chemotherapy Drug Revenue Share by Players (2014-2019)
Figure Global Chemotherapy Drug Revenue Share by Players in 2017
Figure Global Chemotherapy Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Chemotherapy Drug Revenue Market Share in 2018
Figure Global Top 10 Players Chemotherapy Drug Revenue Market Share in 2018
Figure Global Chemotherapy Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Chemotherapy Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Chemotherapy Drug Revenue Market Share by Regions (2014-2019)
Figure Global Chemotherapy Drug Revenue Market Share by Regions (2014-2019)
Figure Global Chemotherapy Drug Revenue Market Share by Regions in 2018
Figure North America Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Europe Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure South America Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Table North America Chemotherapy Drug Revenue by Countries (2014-2019)
Table North America Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure North America Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure North America Chemotherapy Drug Revenue Market Share by Countries in 2018
Figure USA Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Canada Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Table Europe Chemotherapy Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Chemotherapy Drug Revenue Market Share by Countries in 2018
Figure Germany Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure UK Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure France Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Russia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Italy Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Chemotherapy Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Chemotherapy Drug Revenue Market Share by Countries in 2018
Figure China Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Japan Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Korea Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure India Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Table South America Chemotherapy Drug Revenue by Countries (2014-2019)
Table South America Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure South America Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure South America Chemotherapy Drug Revenue Market Share by Countries in 2018
Figure Brazil Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Chemotherapy Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chemotherapy Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Chemotherapy Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure UAE Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Chemotherapy Drug Revenue and Growth Rate (2014-2019)
Table Global Chemotherapy Drug Revenue (Million USD) by Type (2014-2019)
Table Global Chemotherapy Drug Revenue Share by Type (2014-2019)
Figure Global Chemotherapy Drug Revenue Share by Type (2014-2019)
Figure Global Chemotherapy Drug Revenue Share by Type in 2018
Table Global Chemotherapy Drug Revenue Forecast by Type (2019-2024)
Figure Global Chemotherapy Drug Market Share Forecast by Type (2019-2024)
Figure Global Antimetabolites Revenue Growth Rate (2014-2019)
Figure Global Plant Alkaloids Revenue Growth Rate (2014-2019)
Figure Global Alkylating Agents Revenue Growth Rate (2014-2019)
Figure Global Antitumor Antibiotics Revenue Growth Rate (2014-2019)
Table Global Chemotherapy Drug Revenue by Application (2014-2019)
Table Global Chemotherapy Drug Revenue Share by Application (2014-2019)
Figure Global Chemotherapy Drug Revenue Share by Application (2014-2019)
Figure Global Chemotherapy Drug Revenue Share by Application in 2018
Table Global Chemotherapy Drug Revenue Forecast by Application (2019-2024)
Figure Global Chemotherapy Drug Market Share Forecast by Application (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Intravenous Revenue Growth Rate (2014-2019)
Figure Global Chemotherapy Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Chemotherapy Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Chemotherapy Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Chemotherapy Drug Revenue Market Forecast (2019-2024)
Figure Europe Chemotherapy Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Chemotherapy Drug Revenue Market Forecast (2019-2024)
Figure South America Chemotherapy Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Chemotherapy Drug Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介
  • 多発性骨髄腫における従来型化学療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Traditional Chemotherapy Drugs for Multiple Myeloma Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C5861 2019年8月 138Pages
    本調査レポートは、多発性骨髄腫における従来型化学療法薬の世界市場について調べ、まとめました。種類別セグメントは、メルファラン、ビンクリスチン、シクロホスファミド、エトポシド、ドキソルビシン、リポソームドキソルビシン、ベンダムスチン、その他等、用途別セグメントは、コンシューマー事業、エンタープライズ事...
  • 化学療法誘発性好中球減少症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Chemotherapy-Induced Neutropenia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C1198 2019年7月 118Pages
    本調査レポートは、化学療法誘発性好中球減少症治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質療法、コロニー刺激因子療法、顆粒球輸血、脾臓摘出術、その他等、用途別セグメントは、等に区分しました。化学療法誘発性好中球減少症治療の世界市場概観、企業動向、企業別化学療法誘発性好中球減少...
  • 化学療法輸液セットの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）
    Global Chemotherapy Infusion Set Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    B-GIR08C1197 2019年8月 121Pages
    本調査レポートは、化学療法輸液セットの世界市場について調べ、まとめました。種類別セグメントは、フィルター付き、フィルターなし等、用途別セグメントは、病院、医療機器販売店、その他等に区分しました。化学療法輸液セットの世界市場概観、企業動向、企業別化学療法輸液セットシェア、市場規模推移、市場規模予測（2...
  • 化学療法誘発脱毛用頭皮クールデバイスの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）
    Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    B-GIR08C5067 2019年8月 115Pages
    本調査レポートは、化学療法誘発脱毛用頭皮クールデバイスの世界市場について調べ、まとめました。種類別セグメントは、スカルプクールキャップ、スカルプクールシステム等、用途別セグメントは、コンシューマ事業、エンタープライズ事業、オペレーター事業等に区分しました。化学療法誘発脱毛用頭皮クールデバイスの世界市...
  • アテゾリズマブの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）
    Global Atezolizumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    B-GIR08C0404 2019年7月 108Pages
    本調査レポートは、アテゾリズマブの世界市場について調べ、まとめました。種類別セグメントは、用途：単剤、用途：化学療法併用等、用途別セグメントは、等に区分しました。アテゾリズマブの世界市場概観、企業動向、企業別アテゾリズマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北...
  • NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Targeted Drug MEK Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C5672 2019年7月 109Pages
    本調査レポートは、NSCLC用標的薬物MEK阻害剤の世界市場について調べ、まとめました。種類別セグメントは、トラメチニブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬物MEK阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬物MEK阻害剤シェア、市場規模推移、市場規模予測...
  • 抗レトロウイルス薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Antiretroviral Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C0334 2019年7月 118Pages
    本調査レポートは、抗レトロウイルス薬の世界市場について調べ、まとめました。種類別セグメントは、多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他等、用途別セグメントは、等に区分しました。抗レトロウイルス薬の世界市場概観、企業動向、企業別抗レトロウイルス薬シェア、市場規模推移、市場規模予測（2...
  • ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Dolutegravir and Its Combination Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C1834 2019年8月 116Pages
    本調査レポートは、ドルテグラビル及び併用薬の世界市場について調べ、まとめました。種類別セグメントは、ドルテグラビル、アバカビル/ドルテグラビル/ラミブジン、ドルテグラビル/リルピビリン等、用途別セグメントは、医療産業、IT産業、サービス産業等に区分しました。ドルテグラビル及び併用薬の世界市場概観、企...
  • マイクロニードルドラッグデリバリーシステムの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Microneedle Drug Delivery Systems Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C3755 2019年7月 115Pages
    本調査レポートは、マイクロニードルドラッグデリバリーシステムの世界市場について調べ、まとめました。種類別セグメントは、中空マイクロニードル技術、ソリッドマイクロニードル技術、溶解マイクロニードル技術等、用途別セグメントは、等に区分しました。マイクロニードルドラッグデリバリーシステムの世界市場概観、企...
  • NSCLC用標的薬剤VEGFR2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）
    Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR08C5675 2019年7月 107Pages
    本調査レポートは、NSCLC用標的薬剤VEGFR2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、ラムシルマブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬剤VEGFR2阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬剤VEGFR2阻害剤シェア、市場規模...